Literature DB >> 25190361

Disintegration mediated controlled release supersaturating solid dispersion formulation of an insoluble drug: design, development, optimization, and in vitro evaluation.

Sanjay Verma1, Varma S Rudraraju.   

Abstract

The objective of this study was to develop a solid dispersion based controlled release system for drug substances that are poorly soluble in water. A wax-based disintegration mediated controlled release system was designed based on the fact that an amorphous drug can crystallize out from hydrophilic matrices. For this study, cilostazol (CIL) was selected as the model drug, as it exhibits poor aqueous solubility. An amorphous solid dispersion was prepared to assist the drug to attain a supersaturated state. Povidone was used as carrier for solid dispersion (spray drying technique), hydrogenated vegetable oil (HVO) as wax matrix former, and sodium carboxymethyl cellulose (NaCMC) as a disintegrant. The extreme vertices mixture design (EVMD) was applied to optimize the designed and developed composition. The optimized formulation provided a dissolution pattern which was equivalent to the predicted curve, ascertaining that the optimal formulation could be accomplished with EVMD. The release profile of CIL was described by the Higuchi's model better than zero-order, first-order, and Hixson-Crowell's model, which indicated that the supersaturation state of CIL dominated to allow drug release by diffusion rather than disintegration regulated release as is generally observed by Hixson-Crowell's model. The optimized composition was evaluated for disintegration, dissolution, XRD, and stability studies. It was found that the amorphous state as well as the dissolution profile of CIL was maintained under the accelerated conditions of 40°C/75% RH for 6 months.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25190361      PMCID: PMC4309815          DOI: 10.1208/s12249-014-0187-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  33 in total

1.  Possible mechanism for drug retardation from glyceryl monostearate matrix system.

Authors:  K K Peh; C F Wong; K H Yuen
Journal:  Drug Dev Ind Pharm       Date:  2000-04       Impact factor: 3.225

Review 2.  Improving drug solubility for oral delivery using solid dispersions.

Authors:  C Leuner; J Dressman
Journal:  Eur J Pharm Biopharm       Date:  2000-07       Impact factor: 5.571

3.  Preparation and characterization of Furosemide-Eudragit controlled release systems.

Authors:  J M Aceves; R Cruz; E Hernandez
Journal:  Int J Pharm       Date:  2000-02-15       Impact factor: 5.875

Review 4.  Impact of solid state properties on developability assessment of drug candidates.

Authors:  Lian-Feng Huang; Wei-Qin Tong
Journal:  Adv Drug Deliv Rev       Date:  2004-02-23       Impact factor: 15.470

Review 5.  Comparative effects of cilostazol and other therapies for intermittent claudication.

Authors:  D L Dawson
Journal:  Am J Cardiol       Date:  2001-06-28       Impact factor: 2.778

6.  Analysis of the cilostazol safety database.

Authors:  C M Pratt
Journal:  Am J Cardiol       Date:  2001-06-28       Impact factor: 2.778

Review 7.  Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery.

Authors:  Chris Brough; R O Williams
Journal:  Int J Pharm       Date:  2013-06-07       Impact factor: 5.875

Review 8.  Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.

Authors:  Chau Le-Ngoc Vo; Chulhun Park; Beom-Jin Lee
Journal:  Eur J Pharm Biopharm       Date:  2013-09-18       Impact factor: 5.571

9.  Effect of the wettability characteristics of polyethylene glycol derivatives on the drug release of wax matrices.

Authors:  J Dredán; R Fekete; R Zelkó; I Rácz; S Marton
Journal:  Pharmazie       Date:  2000-12       Impact factor: 1.267

10.  Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.

Authors:  Md Selim Reza; Mohiuddin Abdul Quadir; Syed Shabbir Haider
Journal:  J Pharm Pharm Sci       Date:  2003 May-Aug       Impact factor: 2.327

View more
  3 in total

Review 1.  Sustained-release amorphous solid dispersions.

Authors:  Julien Maincent; Robert O Williams
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

2.  Hot Melt Extrusion-Triggered Amorphization as a Continuous Process for Inducing Extended Supersaturable Drug Immediate-Release from saSMSDs Systems.

Authors:  Huan Yu; Yanfei Zhang; Yinghui Ma; Huifeng Zhang; Chengyi Hao; Yong Zhang; Zhengqiang Li; Xianrong Qi; Nianqiu Shi
Journal:  Pharmaceutics       Date:  2022-03-31       Impact factor: 6.525

3.  Self-nanomicellizing solid dispersion of edaravone: part I - oral bioavailability improvement.

Authors:  Ankit Parikh; Krishna Kathawala; Chun Chuan Tan; Sanjay Garg; Xin-Fu Zhou
Journal:  Drug Des Devel Ther       Date:  2018-07-05       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.